TADALAFIL OD!FS

(1) Mixed Hyperlipidemia

(2) Once daily, 2~4 soft capsules per day

(3) Dual Effect to reduce LCL-C and TG Level by patented technology* (3-layer coating)

(4) Combo’s additional decrease effect in residual cardiovascular risk & Omega-3’s multiple effects 
(Lower...

(1) Hypertriglyceridemia; Hyperlipidemia

(2) Once daily, 2g or up to 4g if necessary

(3) Ideal package for administration of ESC recommended strength of Omega-3          (ESC: European Society of Cardiology)

(4) Easy to swallow, patient-friendly dosage form

(1) Chronic iron overload due to blood transfusions
(2) Once daily; in fasting state

(3) Easier administration of powder formulation compared to the original’s dispersible tablet 


(4) Wider range of dosage strength
 
(5) KR-1695970 (Expiration date: ...

(1) Nocturnal enuresis

(2) Once daily; 0.1 or up to 0.4mg before bedtime 


(3) No water needed and relieves stress taking medicine before bedtime

(4) No residual feeling after administration & Sweet taste 

Kuhnil Introduction for License-out- About Kuhnil
- Product Profile (LO)
- R&D Pipelines